MRX 530
Alternative Names: Abbott-76120; ABT-120; Open-Cath-R®; r-UK; Urokinase alfaLatest Information Update: 23 May 2007
At a glance
- Originator ImaRx Therapeutics
- Class Plasminogen activator enzymes; Serine endopeptidases; Thrombolytics
- Mechanism of Action Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Catheter thrombosis
Most Recent Events
- 11 Jan 2006 Phase-III clinical trials in Catheter thrombosis in USA (unspecified route)